Clinical Trials Market, By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional Trials, Observational Trials, and Expanded Access Trials), By Indication (Autoimmune, Blood Disorders, Cancer, Circulatory, CNS, Congenital, CVS, Dermatology, Ear, Gastrointestinal, Genitourinary, Infections, Mental Disorders, Metabolic, Musculoskeletal, Nose, Ophthalmology and Others), and, By Region (North America, Asia Pacific, Europe, Latin America and Middle East & Africa)-Trends, Analysis and Forecast till 2030

Report Code: PMI89519 | Publish Date: March 2024 | No. of Pages: 185

Global Clinical Trials Market By Overview

The clinical trials are experiments that are conducted under clinical research and follow a regulated protocol. The clinical trials are used to evaluate the effectiveness and safety of medications or medical devices by monitoring their effects on large groups of people. The clinical research trials are conducted by government health agencies such as NIH, researchers affiliated with a hospital or university medical program, independent researchers, or private industry. These experiments are primarily performed to obtain data regarding the safety and efficacy of newly developed drugs. The clinical trial data is mandatory for drug approval, as well as for it to be introduced in the market. The clinical trials are performed under three phases (I, II, and III), which depends upon various factors. This process is not only expensive, but also time consuming, and requires expertise at all stages.Clinical Trials Market accounted for US$ 42.4 billion in 2020 and is estimated to be US$ 74.2 billion by 2030 and is anticipated to register a CAGR of 5.5%.

Global Clinical Trials Market By Dynamics

Increase in investment

The globalization leads to an increase in investment in new product development in emerging countries thus leading to the clinical trials market growth. The growing prevalence of rare and new disease cases is a factor boosting the growth of clinical target market.

Increase in patients rate for specific disease

The increase in patients rate for a specific disease, stimulates biopharmaceutical companies to invest more in clinical trials, thus leading to the growth of clinical trials market. In addition, introduction of new medications such as personalized medicine and growing demand for CROs for conducting clinical trials is expected to drive clinical trials market across the globe.  Further, lack of skilled clinical research workforce is restraining the growth of the target market.

 The regulatory quality in emerging markets and stringent regulations for patient enrollment hampers the demand of clinical trials market.

Global Clinical Trials Market By Segmentation

The clinical trials market is segmented by phases, by study design, by indication, and by region.

On the basis of phases, the clinical trial market is sub segmented into phase I, phase II, phase III, phase IV. On the basis of Study Design, the target market is segmented into interventional trials, observational trials, and expanded access trials. On the basis of indications, the clinical trials market is segmented into autoimmune, blood disorders, cancer, circulatory, CNS, congenital, CVS, dermatology, ear, gastrointestinal, genitourinary, infections, mental disorders, metabolic, Musculoskeletal, nose, ophthalmology and others.   

Regional Insights:                                      

For detailed understanding of market dynamics,on the basis of region, the target market is sun segmented into North America, Asia Pacific, Europe, Latin America and Middle East & Africa. North America is expected to be the leading region in the clinical trials market due to the ample of funds availability. Asia Pacific is expected to show a growth in clinical trials market attributed to the initiatives from government and contributions from academic laboratories.                                         

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2030

Market representation

Revenue in USD Million & CAGR from 2020 – 2030

Market Segmentation

By Phase: Phase I, Phase II, Phase III, Phase IV

By Study Design: Interventional Trials, Observational Trials, and Expanded Access Trials

By Indication: Autoimmune, Blood Disorders, Cancer, Circulatory, CNS, Congenital, CVS, Dermatology, Ear, Gastrointestinal, Genitourinary, Infections, Mental Disorders, Metabolic, Musculoskeletal, Nose, Ophthalmology and Others

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Detailed Segmentation:

 Clinical Trials Market, By Phase:

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Clinical Trials Market, By Study Design:

  • Interventional Trials
  • Observational Trials
  • Expanded Access Trials

Clinical Trials Market, By Indication:

  • Autoimmune
  • Blood Disorders
  • Cancer
  • Circulatory
  • CNS
  • Congenital
  • CVS
  • Dermatology
  • Ear
  • Gastrointestinal
  • Genitourinary
  • Infections
  • Mental Disorders
  • Metabolic
  • Musculoskeletal
  • Nose
  • Ophthalmology
  • Others

Clinical Trials Market, By Region:

  • North America
    • Middle East & Africa
      • Middle East & Africa Biologics Safety Testing Market, By Phase
      • Middle East & Africa Biologics Safety Testing Market, By Study Design
      • Middle East & Africa Biologics Safety Testing Market, By Indication
      • Middle East & Africa Biologics Safety Testing Market, By Country
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa
    • Latin America
      • Latin America Biologics Safety Testing Market, By Phase
      • Latin America Biologics Safety Testing Market, By Study Design
      • Latin America Biologics Safety Testing Market, By Indication
      • Latin America Biologics Safety Testing Market, By Country
        • Brazil
        • Mexico
        • Rest of Latin America
    • Asia Pacific
      • Asia Pacific Biologics Safety Testing Market, By Phase
      • Asia Pacific Biologics Safety Testing Market, By Study Design
      • Asia Pacific Biologics Safety Testing Market, By Indication
      • Asia Pacific Biologics Safety Testing Market, By Country
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Europe
      • Europe Biologics Safety Testing Market, By Phase
      • Europe Biologics Safety Testing Market, By Study Design
      • Europe Biologics Safety Testing Market, By Indication
      • Europe Biologics Safety Testing Market, By Country
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • North America Biologics Safety Testing Market, By Phase
    • North America Biologics Safety Testing Market, By Study Design
    • North America Biologics Safety Testing Market, By Indication
    • North America Biologics Safety Testing Market, By Country
      • The U.S.
      • Canada

Global Clinical Trials Market By Key Players

The key operators of clinical trials are Eli Lilly and Company, Novo Nordisk A/S, Ranbaxy Laboratories Ltd, Sanofi Aventis A.S., Roche Group, Biocair International Ltd, Catalent Pharma Solutions, PAREXEL International Corporation, Thermo Fischer Scientific, Inc

Global Clinical Trials Market By Company Profile

  • Eli Lilly and Company
    • Thermo Fischer Scientific, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
    • PAREXEL International Corporation
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
    • Catalent Pharma Solutions
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
    • Biocair International Ltd
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
    • Roche Group
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
    • Sanofi Aventis A.S.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
    • Ranbaxy Laboratories Ltd
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
    • Novo Nordisk A/S
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance

 

Global Clinical Trials Market By Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Preview
    • Executive Summary
    • Key Findings—Global Outlook for Clinical Trials Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Phase
      • Market Snippet, By Study Design
      • Market Snippet, By Indication
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Market Segmentation, By Phase,  2020 – 2030, (US$ Bn)
    • Overview                          
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Phase I
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Phase II
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Phase III
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Phase IV
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
  6. Market Segmentation, By Material Type,  2020 – 2030, (US$ Bn)
    • Overview                
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Interventional Trials
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Observational Trials
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Expanded Access Trials
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
  7. Market Segmentation, By Indication, 2020 – 2030, (US$ Bn)
    • Overview                   
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Autoimmune
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Blood Disorder
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Cancer
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Circulatory
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • CNS
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Congenital
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • CVS
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Dermatology
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Ear
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Gastrointestinal
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Genitourinary
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Infections
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Mental Disorders
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Metabolic
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Musculoskeleton
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Nose
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Ophthalmology
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
  8. Global Market, By Region, 2020 – 2030, (US$ Bn)
    • Overview
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Bn), By Phase, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Study Design, Type, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Indication, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Bn), By Phase, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Study Design, Type, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Indication, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
        • UK
        • France
        • Germany
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Bn), By Phase, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Study Design, Type, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Indication, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
        • India
        • Japan
        • South Korea
        • China
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Bn), By Phase, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Study Design, Type, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Indication, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Bn), By Phase, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Study Design, Type, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Indication, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
      •  
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  10. Company Profiles
    • Eli Lilly and Company
      •  
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
    • Novo Nordisk A/S
      •  
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
    • Ranbaxy Laboratories Ltd
      •  
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
    • Sanofi Aventis A.S.
      •  
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
    • Roche Group
      •  
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
    • Biocair International Ltd
      •  
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
    • Catalent Pharma Solutions
      •  
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
    • PAREXEL International Corporation
      •  
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
    • Thermo Fischer Scientific, Inc.
      •  
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance

The Last Word

  • Future Impact
  • About Us
  • Contact

FAQs

Cinical trials market is segmented by phases, by study design, by indication, and by region.

The globalization leads to an increase in investment in new product development in emerging countries thus leading to the clinical trials market growth.

North America is expected to be the leading region in the clinical trials market due to the ample of funds availability.

The key operators of clinical trials are Eli Lilly and Company, Novo Nordisk A/S, Ranbaxy Laboratories Ltd, Sanofi Aventis A.S., Roche Group, Biocair International Ltd, Catalent Pharma Solutions, PAREXEL International Corporation, Thermo Fischer Scientific, Inc.